Cargando…
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
Spondyloarthritis (SpA) comprises a group of chronic inflammatory diseases with overlapping clinical, genetic and pathophysiological features including back pain, peripheral arthritis, psoriasis, enthesitis and dactylitis. Several cytokines are involved in the pathogenesis of SpA, variously contribu...
Autores principales: | McInnes, Iain B, Szekanecz, Zoltán, McGonagle, Dennis, Maksymowych, Walter P, Pfeil, Alexander, Lippe, Ralph, Song, In-Ho, Lertratanakul, Apinya, Sornasse, Thierry, Biljan, Ana, Deodhar, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071532/ https://www.ncbi.nlm.nih.gov/pubmed/34668515 http://dx.doi.org/10.1093/rheumatology/keab740 |
Ejemplares similares
-
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019) -
JAK inhibitors and infections risk: focus on herpes
zoster
por: Sunzini, Flavia, et al.
Publicado: (2020) -
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
por: Kerrigan, S. A., et al.
Publicado: (2018) -
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019) -
JAK Inhibitors for the Treatment of Axial Spondyloarthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2023)